2004 Anxiety disorders Pharmaceuticals 
Mad in America
JANUARY 29, 2024
If one reads the ADM literature, it is quite apparent that the pharmaceutical industry—with the help of psychiatry—since day one has been involved in a cover up of the dangerousness of these drugs. of the drugs reviewed had two or fewer cases of violence, which is reassuring for most pharmaceuticals. meprobamate) as well.
Mad in America
JANUARY 9, 2024
Academics even boast that EBM shackles the pharmaceutical industry. In 2004, the evidence that pretty well the entire pediatric antidepressant literature was fake, with GSK sued for fraud, caused Cochrane problems. Since 2004, they have been telling us to report adverse effects to the FDA and not to them. Just the opposite.
Mad in America
FEBRUARY 1, 2025
R egardless of the context and cause, distress is increasingly interpreted and diagnosed as a mental illnesscommonly clinical depression and/or anxiety disorder. This process of medicalisation is now all too often a default response to distress and happens on a large scale.
Expert insights. Personalized for you.
102 
Let's personalize your content